The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Takeda Pharmaceutical Co Ltd since 2020.
This trader's CIK number is 1395064.
At the time of last reporting, Takeda Pharmaceutical Co Ltd was the 10% Owner of Phathom Pharmaceuticals, Inc.. (stock ticker symbol PHAT).
Also see all insider trading activities at Phathom Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | PHAT | 0 | $0 | 3,703,703 | $29,999,994 | 0 | $0 |
| 2022 | PHAT | 0 | $0 | 18 | $342 | 0 | $0 |
| 2021 | PHAT | 0 | $0 | 1,177,544 | $26,315,980 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TBIO | 0 | $0 | 7,078,945 | $146,218,360 | 0 | $0 |
1. Phathom Pharmaceuticals, Inc. (PHAT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-24 | PHAT | Sale | 3,703,703 | 8.10 | 29,999,994 |
| 2022-03-14 | PHAT | Sale | 18 | 19.00 | 342 |
| 2021-11-04 | PHAT | Sale | 1,000,001 | 19.93 | 19,925,019 |
| 2021-07-07 | PHAT | Sale | 2,609 | 35.05 | 91,445 |
| 2021-07-01 | PHAT | Sale | 8,226 | 35.16 | 289,226 |
| 2021-07-02 | PHAT | Sale | 100 | 35.01 | 3,501 |
| 2021-06-28 | PHAT | Sale | 370 | 35.08 | 12,979 |
| 2021-06-25 | PHAT | Sale | 24,131 | 35.77 | 863,045 |
| 2021-06-22 | PHAT | Sale | 100 | 35.00 | 3,500 |
| 2021-06-21 | PHAT | Sale | 9,294 | 35.31 | 328,171 |
| 2021-06-17 | PHAT | Sale | 3,305 | 35.08 | 115,939 |
| 2021-06-18 | PHAT | Sale | 5,398 | 35.13 | 189,631 |
| 2021-06-14 | PHAT | Sale | 2,826 | 35.06 | 99,079 |
| 2021-06-07 | PHAT | Sale | 2,264 | 35.05 | 79,353 |
| 2021-06-08 | PHAT | Sale | 100 | 35.00 | 3,500 |
| 2021-06-02 | PHAT | Sale | 4,300 | 35.18 | 151,274 |
| 2021-05-28 | PHAT | Sale | 8,905 | 36.44 | 324,498 |
| 2021-06-01 | PHAT | Sale | 11,211 | 35.88 | 402,194 |
| 2021-05-24 | PHAT | Sale | 10,594 | 35.84 | 379,688 |
| 2021-05-25 | PHAT | Sale | 10,947 | 36.38 | 398,197 |
| 2021-05-20 | PHAT | Sale | 7,098 | 35.10 | 249,139 |
| 2021-05-21 | PHAT | Sale | 11,648 | 35.74 | 416,299 |
| 2021-05-14 | PHAT | Sale | 100 | 35.00 | 3,500 |
| 2021-05-12 | PHAT | Sale | 11,776 | 35.73 | 420,697 |
| 2021-05-13 | PHAT | Sale | 100 | 35.33 | 3,533 |
| 2021-05-07 | PHAT | Sale | 1,011 | 35.03 | 35,415 |
| 2021-05-05 | PHAT | Sale | 6,936 | 35.14 | 243,731 |
| 2021-05-06 | PHAT | Sale | 202 | 35.01 | 7,072 |
| 2021-05-03 | PHAT | Sale | 14,632 | 38.37 | 561,429 |
| 2021-05-04 | PHAT | Sale | 19,360 | 36.93 | 714,926 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-06-30 | TBIO | Sale | 6,824,992 | 20.68 | 141,140,834 |
| 2020-06-03 | TBIO | Sale | 40,086 | 19.75 | 791,698 |
| 2020-06-01 | TBIO | Sale | 108,472 | 20.19 | 2,190,049 |
| 2020-06-02 | TBIO | Sale | 105,395 | 19.89 | 2,095,779 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Takeda Pharmaceutical Co Ltd (10% Owner of Phathom Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.